Any individual with cough, headache, sore throat, breathlessness, body ache, the recent loss of taste or smell, fatigue, and diarrhea should be considered as a suspect case of Covid, says Centre
Topics
Coronavirus | Coronavirus Vaccine | Omicron
A BMC health worker collects swab sample of an outstation passenger for COVID-19 test, at Dadar railway station, in Mumbai (Photo: PTI)
Live news updates: There government has “absolutely no proposal” to extend the deadline for filing income tax returns ending on Friday, said a senior civil servant. Returns until this evening are more than those filed in the previous year, said Revenue Secretary Tarun Bajaj.
Omicron has spread to 23 Indian states and 270 people have been infected with the new coronavirus strain. India recorded 16,764 new cases of Covid-19 and 220 deaths from the disease overnight, said the health ministry on Friday.
Serum Institute Of India has applied to the country’s drug regulator and the health ministry for full approval of its COVID-19 vaccine Covishield, the company’s chief executive said on Friday.
Serum Institute, which produces AstraZeneca’s COVID-19 vaccine under the brand name Covishield, has supplied more than 1.25 billion doses of the shot in India. The Indian government now has enough data to consider a full market authorisation, Serum Institute CEO Adar Poonawalla said on Twitter.
CATCH ALL THE LIVE UPDATES
Auto Refresh